Elevation and Fluctuation of Serum CA19–9 and SPAN-1 Levels After Administration of Sulfonylurea in a Diabetic Patient With Lewis(a–,b–) Blood Phenotype

Yoshioka, Keiji

doi:10.2337/diacare.18.10.1397b

Article navigation

Letters| October 01 1995

Elevation and Fluctuation of Serum CA19–9 and SPAN-1 Levels After Administration of Sulfonylurea in a Diabetic Patient With Lewis(a–,b–) Blood Phenotype

Keiji Yoshioka, MD

First Department of Internal Medicine, Matsushita Memorial Hospital

Osaka, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Keiji Yoshioka, MD, First Department of Internal Medicine, Matsushita Memorial Hospital, 5–55 Sotojimacho, Moriguchi, Osaka 570, Japan.

Diabetes Care 1995;18(10):1397–1399

https://doi.org/10.2337/diacare.18.10.1397b

PubMed:

8721947

Elevation and Fluctuation of Serum CA19–9 and SPAN-1 Levels After Administration of Sulfonylurea in a Diabetic Patient With Lewis(a–,b–) Blood Phenotype

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Elevation and Fluctuation of Serum CA19–9 and SPAN-1 Levels After Administration of Sulfonylurea in a Diabetic Patient With Lewis(a–,b–) Blood Phenotype

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only